The invention relates to a process for preparing the compound of formula 1, a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.
申请公布号
US2012116089(A1)
申请公布日期
2012.05.10
申请号
US201213351621
申请日期
2012.01.17
申请人
BROEDER WOLFGANG;SOBOTTA RAINER;BOEHRINGER INGELHEIM INTERNATIONAL GMBH
